Breaking News

Tweet TWEET

Opko Health, Accuray, Medicines, DaVita, and DENTSPLY Intl. Early Briefing and Review

Opko Health, Accuray, Medicines, DaVita, and DENTSPLY Intl. Early Briefing and
                                    Review

PR Newswire

LONDON, April 15, 2013

LONDON, April 15, 2013 /PRNewswire/ --

One of the most controversial features of the Affordable Care Act (ACA) has
been the 2.3% tax on total sales of taxable medical devices by medical
equipment & supplies companies. The controversial tax will lead to higher
costs for medical devices companies such as Accuray Incorporated (NASDAQ:
ARAY) and DENTSPLY International Inc. (NASDAQ: XRAY). On March 21, however,
the Senate voted 79 to 20 to pass a non-binding budget amendment, which
encourages the repeal of the medical device excise tax. The ACA is also
expected to have a significant impact on other players in the healthcare
industry, including Opko Health Inc. (NYSE: OPK), The Medicines Company
(NASDAQ: MDCO), and DaVita Healthcare Partners Inc. (NYSE: DVA). Healthcare
stocks ended mostly lower on Friday, tracking losses in the broad market,
which struggled following the release of some disappointing economic data.
StockCall has released free charting and technical research on these
aforementioned companies. Register to read these reports at

http://www.stockcall.com/report 

Shares of Opko Health Inc. ended marginally lower in Friday's trading session.
The stock closed 0.28% lower at $7.17 on volume of 807,625. Despite the
pullback last Friday, Opko's shares have gained more than 3.10% in the last
three sessions. The company's shares are currently trading close to their
52-week high of $7.22. The stock has had an excellent run so far in 2013,
gaining more than 49%. Sign up for the free report on OPK at

http://www.StockCall.com/OPK041513.pdf

Shares of Accuray Incorporated fluctuated between gains and losses on Friday
before finishing the day flat at $4.81. Despite struggling for direction last
Friday, shares of ARAY have gained nearly 3.90% in the last three trading
sessions. The stock recently crossed above its 50-day moving average, which is
a bullish signal. The positive trend is further confirmed by its MACD chart.
ARAY free technical report can be accessed by signing up at

http://www.StockCall.com/ARAY041513.pdf

Shares of The Medicines Company's shares posted modest gains in Friday's
session. The stock closed 0.21% higher at $32.82 on volume of 408,552. The
company shares have gained 3.40% in the last three trading sessions, which
indicates that market sentiment is currently bullish on the stock. It is
currently trading 6.73% below its 52-week high. Year-to-date, shares of MDCO
have gained nearly 37%, outperforming the S&P 500. Free report on MDCO can be
accessed by registering at

http://www.StockCall.com/MDCO041513.pdf

Shares of DaVita Healthcare Partners Inc. edged lower on Friday; however, the
losses were limited. The stock closed 0.11% lower at $126.91 on volume of
447,300. The company's shares have outperformed the S&P 500 so far in 2013,
gaining more than 14.80%, compared to a gain of more than 11.40% for the S&P
500. DaVita's shares are currently trading well above its 50-day and 200-day
moving averages, which is a bullish signal. Register with StockCall and
download the research on DVA for free at

http://www.StockCall.com/DVA041513.pdf

Shares of DENTSPLY International Inc. edged lower in Friday's trading
session. The stock fell to an intra-day low of $41.89 before paring some of
the losses to finish the day 0.43% lower at $42.04 on above average volume of
680,800. Despite the decline last Friday, DENTSPLY's shares have gained nearly
1.80% in the last three sessions. The stock is currently struggling to break
through $42.50 resistance level. It has support at around $41.50. Read the
full free research on XRAY by signing up to StockCall at

http://www.StockCall.com/XRAY041513.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise
and comprehensive research and opinions on stocks making the headlines. Sign
up today to talk to our financial analyst at

http://www.stockcall.com 

SOURCE StockCall.com

Contact: Contact Person: William T. Knight, Email: info@stockcall.com, Contact
Number: +1(646)396-9857 (9:00 am EST - 01:30 pm EST)